Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.

In a wellness landscape crowded with generic solutions, Remedy's Nutrition® shifts the focus to individualized biological ...

REITs are positioned for multi-year outperformance, with accelerating AFFO growth, healthy balance sheets, and discounted ...

Mars is no longer just a blank red canvas for planetary scientists. A new generation of high resolution maps is turning the ...

Rivers deliver freshwater, nutrients, and carbon to Earth's oceans, influencing the chemistry of coastal seawater worldwide.

A new advance in bromine-based flow batteries could remove one of the biggest obstacles to long-lasting, affordable energy ...

The national debt looks out of control. But a new reality is setting in that may change the calculus and ensure broad ...

Karthik Ramgopal and Daniel Hewlett discuss the evolution of AI at LinkedIn, from simple prompt chains to a sophisticated ...

Energy Transfer expected to invest about $4.6 billion in growth capital projects last year, which is below its initial ...

NextEra Energy sees the potential to deliver 8%+ compound annual earnings growth over the next decade. 10 stocks we like better than ConocoPhillips › The energy sector had a rather quiet year. The ...

Kingsway Search Xcelerator's 13th AcquisitionOutsourced accounting services provider with strong recurring revenue and organic growthUnaudited pro-forma annual adjusted EBITDA of $0.4 millionRavix Gro ...